TGFB1 and systemic sclerosis: Given TGF‐β1 increases glycolysis and is known to be elevated in SSc, it may be that the combination of TGF‐β1‐enhanced glycolysis and endogenous up‐regulation of glutamine metabolism is key to the development of fibrotic skin lesions in SSc.